The Side-Out Protocol is a pilot study funded by The Side-Out Foundation. It focuses on finding effective treatment for patients with stage 4 (metastatic) breast cancer. Stage 4 is the most advanced form of breast cancer, and there is currently no cure for it.
Researchers for the Side-Out Protocol study a patient's tumor tissue using two different tumor analysis techniques: genomic and proteomic profiling. The goal is to find the best treatment for each patient enrolled in the trial, and the thinking behind it is that each patient's tumor is different and will thus respond to different drugs.
Scientists and physicians hope that personalized medicine such as the Side-Out Protocol will offer the best possible treatment for each individual patient, and researchers for Side-Out's study hope their work will benefit patients who have few treatment options left.